The healthcare industry talks a lot about “change management,” the idea that through careful stewardship, the process of change can be made a little bit easier. The problem is, it’s a lot easier to talk about change than it is to manage it well. This is especially difficult when it comes to digital transformation, a space that is evolving almost too fast to keep up with. So how should leaders be thinking about navigating change in such a complex environment? To answer that question, in the first episode of a two-part series on managing digital change, host Rachel (Rae) Woods invites Advisory Board digital health expert <a href= "https://www.advisory.com/expert-directory/john-league?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e233_2024&utm_content=description"> John League</a>, and later, Optum Advisory Vice President of Digital Transformation, Matt Matousek, to break down why the industry might need to shy away from the term “change management”, what it means to manage change well, and give on-the-ground examples of organizations who have had success with digital transformation. Links: <ul> <li><a href= "https://www.linkedin.com/pulse/stop-saying-change-management-john-league-ijb4e/?trackingId=Rgd4vklmcF3oOeaKW9u4FA%3D%3D"> John’s LinkedIn post</a></li> <li><a href= "https://business.optum.com/en/consulting/advisory.html?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e233_2024&utm_content=description"> Optum Advisory: Healthcare Consulting Services</a></li> <li><a href= "https://radioadvisory.fireside.fm/214?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e233_2024&utm_content=description"> Ep. 214: Is Governance the answer to AI integration? Duke says yes.</a></li> <li><a href= "https://www.advisory.com/topics/digital-health/2023/12/4-key-issues-that-will-shape-the-future-of-digital-health?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e233_2024&utm_content=description"> 4 key issues that will shape the future of digital health</a></li> </ul> We are pausing release of Radio Advisory episodes out of respect for the tragic passing of Brian Thompson. We will resume this podcast in the new year. <a href= "https://web.cvent.com/event/b30acda9-25ab-407d-b73e-7a70fa1251a4/summary?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e233_2024&utm_content=poa"> The state of the industry: What healthcare leaders need to know for 2025</a> <a href= "https://www.advisory.com/executive-briefing-early-access?utm_source=podcast&utm_medium=link&utm_campaign=50324&utm_externalid=none&utm_assetid=none&utm_content=x_x_x_soi_other_shownotes_x_x_earlyaccess"> Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing.</a> Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

<description>&lt;p&gt;The healthcare industry talks a lot about “change management,” the idea that through careful stewardship, the process of change can be made a little bit easier. The problem is, it’s a lot easier to talk about change than it is to manage it well. This is especially difficult when it comes to digital transformation, a space that is evolving almost too fast to keep up with. So how should leaders be thinking about navigating change in such a complex environment?&lt;/p&gt; &lt;p&gt;To answer that question, in the first episode of a two-part series on managing digital change, host Rachel (Rae) Woods invites Advisory Board digital health expert &lt;a href= "https://www.advisory.com/expert-directory/john-league?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e233_2024&amp;utm_content=description"&gt; John League&lt;/a&gt;, and later, Optum Advisory Vice President of Digital Transformation, Matt Matousek, to break down why the industry might need to shy away from the term “change management”, what it means to manage change well, and give on-the-ground examples of organizations who have had success with digital transformation.&lt;/p&gt; &lt;p&gt;Links:&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a href= "https://www.linkedin.com/pulse/stop-saying-change-management-john-league-ijb4e/?trackingId=Rgd4vklmcF3oOeaKW9u4FA%3D%3D"&gt; John’s LinkedIn post&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://business.optum.com/en/consulting/advisory.html?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e233_2024&amp;utm_content=description"&gt; Optum Advisory: Healthcare Consulting Services&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://radioadvisory.fireside.fm/214?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e233_2024&amp;utm_content=description"&gt; Ep. 214: Is Governance the answer to AI integration? Duke says yes.&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/digital-health/2023/12/4-key-issues-that-will-shape-the-future-of-digital-health?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e233_2024&amp;utm_content=description"&gt; 4 key issues that will shape the future of digital health&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt; &lt;hr /&gt; &lt;p&gt;We are pausing release of &lt;i&gt;Radio Advisory&lt;/i&gt; episodes out of respect for the tragic passing of Brian Thompson. We will resume this podcast in the new year.&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://web.cvent.com/event/b30acda9-25ab-407d-b73e-7a70fa1251a4/summary?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e233_2024&amp;utm_content=poa"&gt; The state of the industry: What healthcare leaders need to know for 2025&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://www.advisory.com/executive-briefing-early-access?utm_source=podcast&amp;utm_medium=link&amp;utm_campaign=50324&amp;utm_externalid=none&amp;utm_assetid=none&amp;utm_content=x_x_x_soi_other_shownotes_x_x_earlyaccess"&gt; Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing.&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;&lt;i&gt;Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.&lt;/i&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.&lt;/p&gt;</description>

In this episode, the first of a two-part series on managing digital change, host Rachel Woods has a conversation with Advisory Board digital health expert John League and Optum Advisory Vice President of Digital Transformation Matt Matousek about the pitf

233: Your digital strategy needs more than “change management”

Employers have been saying for years that they can’t absorb any more cost growth for health insurance; health plans feel like they’ve squeezed about as much juice as possible out of traditional cost mitigation levers. Both are looking for creative alternatives to curb rising health costs. Enter ICHRAs. Usually, when we talk about the health insurance landscape, we focus on Medicare, Medicaid, or employer-sponsored insurance. But roughly 21 million people in the US are covered by individual marketplace plans, and in 2020, a new type of plan hit the individual market, moving health insurance from a “defined benefit” to a “defined contribution” in an effort to curb employer health costs. In this episode, host Abby Burns invites Advisory Board health plan expert <a href= "https://www.advisory.com/expert-directory/morghen-philippi?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e232_2024&utm_content=description"> Morghen Philippi</a> to shed light on what Individual Coverage Health Reimbursement Arrangements, or ICHRAs, actually are, how employers, plans, and providers are responding to their rise, and what leaders need to keep an eye on when it comes to these plans. Note: This episode was recorded prior to the 2024 elections. Given the results, it is unlikely that the enhanced subsidies referenced in this episode will be renewed, which will affect the health of the individual marketplace. If enhanced subsidies expire at the end of 2025, you can expect it to have a direct impact on the individual market and on ICHRA viability, specifically. That said, because of the first Trump administration’s role in establishing the ICHRA model, the incoming administration may work to support ICHRA growth. Links: <ul> <li><a href= "https://www.advisory.com/daily-briefing/2023/08/15/radio-advisory-165?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e232_2024&utm_content=description"> Is the cost of employer-sponsored insurance at a tipping point?</a></li> <li><a href= "https://www.advisory.com/topics/health-plan/2024/10/health-insurance-market-outlook?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e232_2024&utm_content=description"> Market outlook for individual and small group health insurance</a></li> <li><a href= "https://radioadvisory.fireside.fm/176?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e232_2024&utm_content=description"> Ep. 176: Test, fail, and test again: Morgan Health's approach to employer costs</a></li> <li><a href= "https://www.advisory.com/topics/cost-control/2024/10/enhanced-subsidies?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e232_2024&utm_content=description"> Enhanced subsidies propelled ACA marketplace enrollment. What’s next?</a></li> </ul> <a href= "https://web.cvent.com/event/f9cc185f-84e7-4d8a-93ce-be6d433d1438/summary?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e232_2024&utm_content=poa"> What health system growth will look like in 2025</a> <a href= "https://www.advisory.com/executive-briefing-early-access?utm_source=podcast&utm_medium=link&utm_campaign=50324&utm_externalid=none&utm_assetid=none&utm_content=x_x_x_soi_other_shownotes_x_x_earlyaccess"> Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing.</a> A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

<description>&lt;p&gt;Employers have been saying for years that they can’t absorb any more cost growth for health insurance; health plans feel like they’ve squeezed about as much juice as possible out of traditional cost mitigation levers. Both are looking for creative alternatives to curb rising health costs. Enter ICHRAs.&lt;/p&gt; &lt;p&gt;Usually, when we talk about the health insurance landscape, we focus on Medicare, Medicaid, or employer-sponsored insurance. But roughly 21 million people in the US are covered by individual marketplace plans, and in 2020, a new type of plan hit the individual market, moving health insurance from a “defined benefit” to a “defined contribution” in an effort to curb employer health costs.&lt;/p&gt; &lt;p&gt;In this episode, host Abby Burns invites Advisory Board health plan expert &lt;a href= "https://www.advisory.com/expert-directory/morghen-philippi?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e232_2024&amp;utm_content=description"&gt; Morghen Philippi&lt;/a&gt; to shed light on what Individual Coverage Health Reimbursement Arrangements, or ICHRAs, actually are, how employers, plans, and providers are responding to their rise, and what leaders need to keep an eye on when it comes to these plans.&lt;/p&gt; &lt;p&gt;&lt;b&gt;Note&lt;/b&gt;: This episode was recorded prior to the 2024 elections. Given the results, it is unlikely that the enhanced subsidies referenced in this episode will be renewed, which will affect the health of the individual marketplace. If enhanced subsidies expire at the end of 2025, you can expect it to have a direct impact on the individual market and on ICHRA viability, specifically. That said, because of the first Trump administration’s role in establishing the ICHRA model, the incoming administration may work to support ICHRA growth.&lt;/p&gt; &lt;p&gt;Links:&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/daily-briefing/2023/08/15/radio-advisory-165?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e232_2024&amp;utm_content=description"&gt; Is the cost of employer-sponsored insurance at a tipping point?&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/health-plan/2024/10/health-insurance-market-outlook?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e232_2024&amp;utm_content=description"&gt; Market outlook for individual and small group health insurance&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://radioadvisory.fireside.fm/176?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e232_2024&amp;utm_content=description"&gt; Ep. 176: Test, fail, and test again: Morgan Health's approach to employer costs&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/cost-control/2024/10/enhanced-subsidies?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e232_2024&amp;utm_content=description"&gt; Enhanced subsidies propelled ACA marketplace enrollment. What’s next?&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://web.cvent.com/event/f9cc185f-84e7-4d8a-93ce-be6d433d1438/summary?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e232_2024&amp;utm_content=poa"&gt; What health system growth will look like in 2025&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://www.advisory.com/executive-briefing-early-access?utm_source=podcast&amp;utm_medium=link&amp;utm_campaign=50324&amp;utm_externalid=none&amp;utm_assetid=none&amp;utm_content=x_x_x_soi_other_shownotes_x_x_earlyaccess"&gt; Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing.&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.&lt;/p&gt;</description>

In this episode, host Abby Burns invites Advisory Board health plan expert Morghen Philippi to shed light on a recent addition to the health insurance landscape that’s aimed at curbing cost growth: ICHRAs. They’ll unpack what ICHRAs actually are, how 

232: The rise of ICHRAs: Why some employers are turning to the individual market

Last week on Radio Advisory, we broke down what healthcare leaders need to know for 2025 and beyond following the recent elections. But before we move on from 2024 completely, we have to acknowledge that there’s been a lot moving in the policy space this year, and frankly, there have probably been a few important policy areas on your radar that we haven’t discussed. That’s why this week, host Abby Burns invites Advisory Board experts <a href= "https://www.advisory.com/expert-directory/regina-lohr?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> Gina Lohr</a>, <a href= "https://www.advisory.com/expert-directory/sarah-hostetter?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> Sarah Roller</a>, and <a href= "https://www.advisory.com/expert-directory/paul-trigonoplos?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> Paul Trigonoplos</a> to dive into three major policy areas of the last year: Medicare drug negotiations, changes to physician employment and payment, and an emerging mandatory bundled payment model called TEAM. The experts unpack how these policies are affecting the industry, how the elections outcomes may impact them, and, critically, how much attention leaders should be paying them going forward. In other words, should leaders consider each policy a big deal, a little deal, or no deal? Links: <ul> <li><a href= "https://radioadvisory.fireside.fm/230?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> Ep. 230: Elections results are in: What healthcare leaders need to know</a></li> <li><a href= "https://www.advisory.com/daily-briefing/2024/11/07/ballot-measures?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> State-level healthcare ballot measures that passed (and failed)</a></li> <li><a href= "https://www.advisory.com/topics/policy-and-payment/2024/11/cms-team-payment-model?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> CMS’ TEAM payment model is here. How should hospitals prepare?</a></li> <li><a href= "https://www.advisory.com/topics/policy-and-payment/2024/11/transforming-episode-accountability-model?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> Transforming Episode Accountability Model (TEAM)</a></li> <li><a href= "https://www.advisory.com/topics/policy-and-payment/2024/01/cms-vbp-models?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> Your guide to CMS' 14 value-based payment models</a></li> <li><a href= "https://www.advisory.com/daily-briefing/2024/08/15/medicare-drug-prices?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> Medicare announces 10 new drug prices following negotiations</a></li> <li><a href= "https://www.advisory.com/daily-briefing/2024/08/21/ftc-noncompetes?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> A federal judge just blocked FTC's noncompete ban</a></li> <li><a href= "https://www.advisory.com/topics/market-analytics-and-forecasting/2018/09/benchmark-generator?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> The Hospital Benchmark Generator</a></li> <li><a href= "https://www.advisory.com/topics/market-analytics-and-forecasting/2019/05/market-scenario-planner?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=description"> Market Scenario Planner</a></li> </ul> (Correction: An earlier version of this episode misstated that there is a $200 out-of-pocket cap on drug spending going into place. That number is $2,000 and references the Medicare Part D out-of-pocket cap set to begin in 2025. We have removed the number from the audio.) <a href= "https://www.advisory.com/executive-briefing-early-access?utm_source=podcast&utm_medium=link&utm_campaign=50324&utm_externalid=none&utm_assetid=none&utm_content=x_x_x_soi_other_shownotes_x_x_earlyaccess"> Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing.</a> <a href= "https://www.advisory.com/sponsored/labs-embrace-innovation?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=poa"> 2 ways labs can embrace innovation to drive revenue and accelerate growth</a> <a href= "https://www.advisory.com/topics/market-analytics-and-forecasting/2019/05/market-scenario-planner?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e231_2024&utm_content=poa"> Market Scenario Planner</a> A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

<description>&lt;p&gt;Last week on Radio Advisory, we broke down what healthcare leaders need to know for 2025 and beyond following the recent elections. But before we move on from 2024 completely, we have to acknowledge that there’s been a lot moving in the policy space this year, and frankly, there have probably been a few important policy areas on your radar that we haven’t discussed.&lt;/p&gt; &lt;p&gt;That’s why this week, host Abby Burns invites Advisory Board experts &lt;a href= "https://www.advisory.com/expert-directory/regina-lohr?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; Gina Lohr&lt;/a&gt;, &lt;a href= "https://www.advisory.com/expert-directory/sarah-hostetter?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; Sarah Roller&lt;/a&gt;, and &lt;a href= "https://www.advisory.com/expert-directory/paul-trigonoplos?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; Paul Trigonoplos&lt;/a&gt; to dive into three major policy areas of the last year: Medicare drug negotiations, changes to physician employment and payment, and an emerging mandatory bundled payment model called TEAM. The experts unpack how these policies are affecting the industry, how the elections outcomes may impact them, and, critically, how much attention leaders should be paying them going forward. In other words, should leaders consider each policy a big deal, a little deal, or no deal?&lt;/p&gt; &lt;p&gt;Links:&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a href= "https://radioadvisory.fireside.fm/230?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; Ep. 230: Elections results are in: What healthcare leaders need to know&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/daily-briefing/2024/11/07/ballot-measures?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; State-level healthcare ballot measures that passed (and failed)&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/policy-and-payment/2024/11/cms-team-payment-model?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; CMS’ TEAM payment model is here. How should hospitals prepare?&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/policy-and-payment/2024/11/transforming-episode-accountability-model?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; Transforming Episode Accountability Model (TEAM)&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/policy-and-payment/2024/01/cms-vbp-models?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; Your guide to CMS' 14 value-based payment models&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/daily-briefing/2024/08/15/medicare-drug-prices?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; Medicare announces 10 new drug prices following negotiations&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/daily-briefing/2024/08/21/ftc-noncompetes?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; A federal judge just blocked FTC's noncompete ban&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/market-analytics-and-forecasting/2018/09/benchmark-generator?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; The Hospital Benchmark Generator&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/market-analytics-and-forecasting/2019/05/market-scenario-planner?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=description"&gt; Market Scenario Planner&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt; &lt;p&gt;(&lt;b&gt;Correction&lt;/b&gt;: An earlier version of this episode misstated that there is a $200 out-of-pocket cap on drug spending going into place. That number is $2,000 and references the Medicare Part D out-of-pocket cap set to begin in 2025. We have removed the number from the audio.)&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://www.advisory.com/executive-briefing-early-access?utm_source=podcast&amp;utm_medium=link&amp;utm_campaign=50324&amp;utm_externalid=none&amp;utm_assetid=none&amp;utm_content=x_x_x_soi_other_shownotes_x_x_earlyaccess"&gt; Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing.&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://www.advisory.com/sponsored/labs-embrace-innovation?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=poa"&gt; 2 ways labs can embrace innovation to drive revenue and accelerate growth&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://www.advisory.com/topics/market-analytics-and-forecasting/2019/05/market-scenario-planner?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e231_2024&amp;utm_content=poa"&gt; Market Scenario Planner&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.&lt;/p&gt;</description>

Drugs, docs, and mandatory payment models. In this episode, host Abby Burns invites Advisory Board experts Gina Lohr, Sarah Roller, and Paul Trigonoplos to unpack three major health policy topics of 2024. The experts explore how these policies are affecti

231: Big deal, little deal, or no deal? A 2024 health policy retrospective

(Note: This episode was recorded on November 7, 2024) The results of the 2024 elections are in: Donald Trump will be the 47th President of the United States, and we are all but certain to have a Republican trifecta at the federal level. Admittedly, there’s a lot we don’t know about what healthcare will look like under a second Trump administration—a lot will depend on who is appointed to key leadership positions overseeing federal health agencies and Congressional committees. But while we wait for those appointments, what can we anticipate based on President-elect Trump’s first term, campaign, and the Republican platform? This week, hosts Rachel (Rae) Woods and Abby Burns invite Advisory Board experts <a href= "https://www.advisory.com/expert-directory/natalie-trebes?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e230_2024&utm_content=description"> Natalie Trebes</a> and <a href= "https://www.advisory.com/expert-directory/ben-palmer?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e230_2024&utm_content=description"> Ben Palmer</a> to break down the implications of a second Trump term on the healthcare industry. They unpack how power dynamics have shifted since the first administration, and what we’re likely to see on issues like the ACA, enhanced subsidies, Medicaid, drug pricing, abortion, and more. Links: <ul> <li><a href= "https://www.advisory.com/election?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e230_2024&utm_content=description"> What the 2024 elections mean for healthcare</a></li> <li><a href= "https://www.advisory.com/daily-briefing/2024/11/06/day-after-election?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e230_2024&utm_content=description"> The election is over. Here's how to talk to your team today.</a></li> <li><a href= "https://radioadvisory.fireside.fm/206?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e230_2024&utm_content=description"> Ep. 206: 24th Secretary of HHS Alex Azar shares his vision on healthcare transformation</a></li> <li><a href= "https://www.advisory.com/daily-briefing/2024/11/07/ballot-measures?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e230_2024&utm_content=description"> State-level healthcare ballot measures that passed (and failed)</a></li> <li><a href= "https://www.advisory.com/daily-briefing/2024/10/29/election?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e230_2024&utm_content=description"> Why healthcare leaders should look to their state elections more than the national race</a></li> </ul> <a href= "https://www.advisory.com/memberships/subscribe-public-daily-briefing?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e230_2024&utm_content=poa"> Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day.</a> A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

<description>&lt;p&gt;&lt;i&gt;(Note: This episode was recorded on November 7, 2024)&lt;/i&gt;&lt;/p&gt; &lt;p&gt;The results of the 2024 elections are in: Donald Trump will be the 47th President of the United States, and we are all but certain to have a Republican trifecta at the federal level. Admittedly, there’s a lot we &lt;i&gt;don’t&lt;/i&gt; know about what healthcare will look like under a second Trump administration—a lot will depend on who is appointed to key leadership positions overseeing federal health agencies and Congressional committees. But while we wait for those appointments, what can we anticipate based on President-elect Trump’s first term, campaign, and the Republican platform?&lt;/p&gt; &lt;p&gt;This week, hosts Rachel (Rae) Woods and Abby Burns invite Advisory Board experts &lt;a href= "https://www.advisory.com/expert-directory/natalie-trebes?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e230_2024&amp;utm_content=description"&gt; Natalie Trebes&lt;/a&gt; and &lt;a href= "https://www.advisory.com/expert-directory/ben-palmer?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e230_2024&amp;utm_content=description"&gt; Ben Palmer&lt;/a&gt; to break down the implications of a second Trump term on the healthcare industry. They unpack how power dynamics have shifted since the first administration, and what we’re likely to see on issues like the ACA, enhanced subsidies, Medicaid, drug pricing, abortion, and more.&lt;/p&gt; &lt;p&gt;Links:&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/election?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e230_2024&amp;utm_content=description"&gt; What the 2024 elections mean for healthcare&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/daily-briefing/2024/11/06/day-after-election?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e230_2024&amp;utm_content=description"&gt; The election is over. Here's how to talk to your team today.&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://radioadvisory.fireside.fm/206?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e230_2024&amp;utm_content=description"&gt; Ep. 206: 24th Secretary of HHS Alex Azar shares his vision on healthcare transformation&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/daily-briefing/2024/11/07/ballot-measures?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e230_2024&amp;utm_content=description"&gt; State-level healthcare ballot measures that passed (and failed)&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/daily-briefing/2024/10/29/election?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e230_2024&amp;utm_content=description"&gt; Why healthcare leaders should look to their state elections more than the national race&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://www.advisory.com/memberships/subscribe-public-daily-briefing?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e230_2024&amp;utm_content=poa"&gt; Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day.&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.&lt;/p&gt;</description>

The 2024 elections are over. In this episode, hosts Rachel Woods and Abby Burns invite Advisory Board experts Natalie Trebes and Ben Palmer to break down what healthcare leaders can anticipate under incoming federal and state leadership bodies, what impac

230: Elections results are in: What healthcare leaders need to know

Conversations around GLP-1s in today’s healthcare market are mixed. Some stakeholders are thrilled with their potential, while others are filled with questions and even anxiety about how these powerful and popular drugs will impact their business. Many in the industry have been asking for months: “What can GLP-1s do?” But maybe this is the wrong question. Leaders should be asking “What CAN’T GLP-1s do?” To answer that question, live from HLTH 2024, host Rachel (Rae) Wood invites Rob MacNaughton, CEO of lifestyle intervention and obesity management organization Calibrate, Rita Glaze-Rowe, President at life sciences research organization Real Chemistry, and Dr. Spencer Nadolsky, lipid and obesity specialist and founder to break down the cross-industry perspective on GLP-1s and how the healthcare leaders should be thinking about both the potential and limitations of these novel therapies. In a market that is buzzing around the novel medications, these experts suggest a new focus on comprehensive weight management programs. Links: <ul> <li><a href= "https://www.joincalibrate.com/resources/treating-obesity-at-scale?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=description"> Treating Obesity At Scale: Real-World Outcomes Using Medication And Intensive Lifestyle Intervention | Calibrate</a></li> <li><a href= "https://www.realchemistry.com/?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=description"> Real Chemistry - AI and Ideas Transforming Healthcare</a></li> <li><a href= "https://radioadvisory.fireside.fm/222?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=description"> Ep. 222: It's not just GLP-1s; here's what comprehensive weight management looks like</a></li> <li><a href= "https://radioadvisory.fireside.fm/159?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=description"> Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs</a></li> <li><a href= "https://www.advisory.com/topics/clinical-services/2024/02/comprehensive-care-for-obesity?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=description"> How 3 health systems provide comprehensive care for obesity</a></li> <li><a href= "https://www.advisory.com/topics/clinical-services/2024/06/4-key-elements-of-comprehensive-obesity-care?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=description"> 4 key elements of comprehensive obesity care (and how they look in practice)</a></li> </ul> <a href= "https://www.advisory.com/memberships/subscribe-public-daily-briefing?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=poa"> Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day.</a> <a href= "https://www.advisory.com/elections?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=poa"> What the 2024 elections mean for healthcare</a> <a href= "https://web.cvent.com/event/940c9ec2-ec18-4c1d-a078-7c229f68cc52/summary?utm_source=radioadvisory&utm_medium=podcast&utm_campaign=e229_2024&utm_content=poa"> [Webinar, 10/24] How the 2024 elections could impact the healthcare industry</a> A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

<description>&lt;p&gt;Conversations around GLP-1s in today’s healthcare market are mixed. Some stakeholders are thrilled with their potential, while others are filled with questions and even anxiety about how these powerful and popular drugs will impact their business. Many in the industry have been asking for months: “What can GLP-1s do?” But maybe this is the wrong question. Leaders should be asking “What CAN’T GLP-1s do?”&lt;/p&gt; &lt;p&gt;To answer that question, live from HLTH 2024, host Rachel (Rae) Wood invites Rob MacNaughton, CEO of lifestyle intervention and obesity management organization Calibrate, Rita Glaze-Rowe, President at life sciences research organization Real Chemistry, and Dr. Spencer Nadolsky, lipid and obesity specialist and founder to break down the cross-industry perspective on GLP-1s and how the healthcare leaders should be thinking about both the potential and limitations of these novel therapies. In a market that is buzzing around the novel medications, these experts suggest a new focus on comprehensive weight management programs.&lt;/p&gt; &lt;p&gt;Links:&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a href= "https://www.joincalibrate.com/resources/treating-obesity-at-scale?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=description"&gt; Treating Obesity At Scale: Real-World Outcomes Using Medication And Intensive Lifestyle Intervention | Calibrate&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.realchemistry.com/?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=description"&gt; Real Chemistry - AI and Ideas Transforming Healthcare&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://radioadvisory.fireside.fm/222?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=description"&gt; Ep. 222: It's not just GLP-1s; here's what comprehensive weight management looks like&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://radioadvisory.fireside.fm/159?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=description"&gt; Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/clinical-services/2024/02/comprehensive-care-for-obesity?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=description"&gt; How 3 health systems provide comprehensive care for obesity&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://www.advisory.com/topics/clinical-services/2024/06/4-key-elements-of-comprehensive-obesity-care?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=description"&gt; 4 key elements of comprehensive obesity care (and how they look in practice)&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://www.advisory.com/memberships/subscribe-public-daily-briefing?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=poa"&gt; Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day.&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;&lt;a href= "https://www.advisory.com/elections?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=poa"&gt; What the 2024 elections mean for healthcare&lt;/a&gt;&lt;/p&gt; &lt;p&gt;&lt;a href= "https://web.cvent.com/event/940c9ec2-ec18-4c1d-a078-7c229f68cc52/summary?utm_source=radioadvisory&amp;utm_medium=podcast&amp;utm_campaign=e229_2024&amp;utm_content=poa"&gt; [Webinar, 10/24] How the 2024 elections could impact the healthcare industry&lt;/a&gt;&lt;/p&gt; &lt;hr /&gt; &lt;p&gt;A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.&lt;/p&gt;</description>

In this episode, recorded live from HLTH 2024, host Rae Woods sits down with Calibrate CEO Rob MacNaughton, Real Chemistry President of Transformative Healthcare Markets Rita Glaze-Rowe, and physician founder, Dr. Spencer Nadolsky, to break down both the 

229: Live from HLTH: What Can’t GLP-1s Do?

A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization.   
From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com

Radio Advisory

Details

Recent Episodes